大肠癌肿瘤突变蛋白抗体

首页蛋白库基因库产品会员服务

位置：首页 > 产品库 > 大肠癌肿瘤突变蛋白抗体

立即咨询

大肠癌肿瘤突变蛋白抗体

本产品不向个人销售，仅用作科学研究，不用于任何人体实验及非科研性质的动物实验。

Anti-MCC
Anti-MCC regulator of WNT signaling pathway Antibody

靶标：

MCC

产品别名：

MCC1； MCC； MCC regulator of WNT signaling pathway； MCC regulator of WNT signaling pathway； colorectal mutant cancer protein； MCC, WNT signaling pathway regulator； mutated in colorectal cancers；大肠癌肿瘤突变蛋白；

背景信息：

MUTATED IN COLORECTAL CANCERS(MCC) is a tumor suppressor gene. It is mapped to 5q22.2. This gene suppresses cell proliferation and the Wnt/b-catenin pathway in colorectal cancer cells. MCC also Inhibits DNA binding of b-catenin/TCF/LEF transcription factors, and it is Involved in cell migration independently of RAC1, CDC42 and p21-activated kinase(PAK) activation. What's more, MCC can interact with SCRIB(via phosphorylated PDZ-binding motif), EZR, SNX27, SLC9A3R1 and SLC9A3R2.

宿主：Rbt
类型：Pab
同种型:IgG
应用：WB
纯化方式：亲和纯化
偶联物：Unconjugated
性状：液体
存储溶液：参阅说明书
浓度：Batch dependent (Please refer to the vial label for the specific concentration.)
稀释比例: Optimal dilutions/concentrations should be determined by the end user
储存：经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。
注意事项：仅供实验室使用。不适用于人类或动物的任何临床，治疗或诊断用途。不适合动物或人类食用。